Stocks to sell

Times have been tough for Peloton Interactive (NASDAQ:PTON) stock lately. Its financials have been terrible, and some high-level executives are leaving. Investors who are counting on Peloton’s deal with Dick’s Sporting Goods (NYSE:DKS) to make everything better shouldn’t hold their breath. Remember how Peloton was a darling of the markets during the spread of Covid-19 in early
0 Comments
I’ll be the first to acknowledge that there’s some cache to being a Dow stock. But that doesn’t mean investors should be obligated to buy. When the market turns, sometimes those names become Dow stocks to sell – and that’s where we are today. Of course, it first pays to know exactly what a Dow
0 Comments
Check out recent headlines about Carvana (NYSE:CVNA) stock, and you may start to think the opportunity to bottom-fish in this former stock market high-flier has emerged. Since last year, shares in this automotive e-commerce company have fallen by more than 94%, from an all-time high of $370.10 per share to around $20 per share today.
0 Comments
Cryptocurrencies are still facing a myriad of issues. For one, the value of most cryptos are still hovering around 52-week lows.  Two, the Biden Administration is looking to regulate the sector intensively.  Three, there are concerns about the impact Bitcoin (CCC:BTC-USD) miners are having on the climate.  I also believe the chances of crypto mining being greatly
0 Comments
There was a time, a few years ago, when it was easy to recommend Netflix (NASDAQ:NFLX) stock. Back then, the streaming company was quickly gaining subscribers. However, circumstances have changed and Netflix is actually losing subscribers. Granted, traders are buzzing about Netflix’s likely soon-to-come ad-supported tier. However, investors shouldn’t be overly bullish as introducing ads won’t
0 Comments
The miserable year for tech stocks just won’t end, so nobody could really blame you if you started looking for tech stocks to sell. While tech seemed to have a resurgence in August and gave growth investors some hope in an utterly miserable year on the market, the sector is once again on the downturn.
0 Comments
Reportedly, Biogen (NASDAQ:BIIB) and Japanese pharmaceutical company Eisai (OTCMKTS:ESALY) achieved positive test results for their Alzheimer’s disease treatment. As you might expect, BIIB stock exploded higher on this news. However, these are early-stage results and prospective investors should read the fine print. Besides, if the good news has already been priced in, then buying now is tantamount
0 Comments
What exactly does Ideanomics (NASDAQ:IDEX) stock represent? Is it an electric vehicle (EV) design company? Or a tractor producer? Maybe it’s trying to be a wireless charging provider this week? How about a maker of street sweepers? Frankly, it’s hard to pin this company down, and IDEX investors are understandably unimpressed with the company’s poor financial results.
0 Comments
There’s a saying in investing, attributed to Warren Buffett, that you don’t see who’s swimming naked until the tide goes out.  Essentially, this means that poorly run and troubled companies are most exposed during market downturns. This is certainly proving to be the case this year. With all the major U.S. indices now in bear
0 Comments
Headline inflation numbers continue to run near their highest levels in 40 years. The Federal Reserve hiked interest rates by 75 more basis points in September. Analysts are rightly nervous about how long this rising-price period will persist. However, one key sector of the economy is already signaling that the worst of the inflation has
0 Comments
The potential for high returns and stable income streams have made real estate investment trusts, or REITs, a popular investment vehicle. However, not all REITs are created equal, especially with a potential recession hanging overhead. On today’s list, I take a look at three REITs to sell. The reasoning for my bearishness on these particular
0 Comments
In general, when markets trend lower, it makes sense to invest in blue-chip stocks. They tend to have a low beta and also provide regular cash flows through dividends. Yet, not all blue chips are created equal. Based on macroeconomic or company-specific factors, there are some you want to buy and some blue-chip stocks to
0 Comments
The Fed’s key interest rate target now stands at 3%-3.25%, way up from 0%-0.25% at the beginning of the year. That means, for all companies, borrowing money is becoming much more expensive. As a result, healthcare companies losing a great deal of money will have trouble obtaining new loans they can afford to pay off, and
0 Comments
There’s no doubt about it: XPeng (NYSE:XPEV) wants the world to know that the company just unveiled a new SUV. That’s all fine and well, but was this event enough to assuage investors’ concerns about XPeng? So far, the answer is no. The Chinese automakers’ dwindling deliveries, along with macroeconomic issues, are legitimate issues and could
0 Comments